> PUBLICATION > Research Paper

Research Paper
[Nature Communications, 2024] Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer

Release Time:2025-09-26

Hits:

Title of Paper:[Nature Communications, 2024] Rosiglitazone and trametinib exhibit potent anti-tumor activity in a mouse model of muscle invasive bladder cancer

Journal:Nature Communications

Translation or Not:No

Date of Publication:2024-01

Release Time:2025-09-26

Prev One:[Science Advances, 2024] Epigenetic regulation of p63 blocks squamous-to-neuroendocrine transdifferentiation in esophageal development and malignancy

Next One:[Cell Reports, 2024] Metabolic reprogramming by histone deacetylase inhibition preferentially targets NRF2-activated tumors

Copyright All Rights Reserved Shandong University Address: No. 27 Shanda South Road, Jinan City, Shandong Province, China: 250100
Information desk: (86) - 0531-88395114
On Duty Telephone: (86) - 0531-88364731 Construction and Maintenance: Information Work Office of Shandong University